Status Active legal-status Critical Current Adjusted expiration legal-status Critical Links Assignors: AXELLIA PHARMACEUTICALS APS Application granted granted Critical Publication of US9150894B2 publication Critical patent/US9150894B2/en First worldwide family litigation filed litigation Critical (B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License. Assignors: PETERSEN, CARSTEN OVERBALLE, HANSEN, DENNIS BRIAN, HAUGE, SISSEL, DALE, ELI KARIN, HIRTH, KJERSTI AASTORP, MANSSON, MARTIN Publication of US20100228006A1 publication Critical patent/US20100228006A1/en Assigned to XELLIA PHARMACEUTICALS APS reassignment XELLIA PHARMACEUTICALS APS CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Family has litigation Priority to US15366009P priority Critical Application filed by Xellia Pharmaceuticals ApS filed Critical Xellia Pharmaceuticals ApS Priority to US12/708,539 priority patent/US9150894B2/en Assigned to AXELLIA PHARMACEUTICALS APS reassignment AXELLIA PHARMACEUTICALS APS ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Original Assignee Xellia Pharmaceuticals ApS Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.) ( en Inventor Martin Mansson Eli Karin Dale Sissel Hauge Carsten Overballe-Petersen Kjersti Aastorp Hirth Dennis Brian Hansen Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.) Active, expires Application number US12/708,539 Other versions US20100228006A1 Google Patents Process for purifying lipopeptidesĭownload PDF Info Publication number US9150894B2 US9150894B2 US12/708,539 US70853910A US9150894B2 US 9150894 B2 US9150894 B2 US 9150894B2 US 70853910 A US70853910 A US 70853910A US 9150894 B2 US9150894 B2 US 9150894B2 Authority US United States Prior art keywords elution buffer daptomycin process according eluate reverse phase Prior art date Legal status (The legal status is an assumption and is not a legal conclusion. Google Patents US9150894B2 - Process for purifying lipopeptides HW resin molar mass ranges span peptide and protein sizes between 100 to 5 x 107 daltons. US9150894B2 - Process for purifying lipopeptides
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |